Glenmark’s new immune-oncology drug candidate granted FDA approval for Phase 1/2 clinical trial
![](https://wellnessnews24.com/wp-content/uploads/2023/03/pexels-thirdman-7659566-720x530.jpg)
1 min read
Glenmark Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) to conduct a Phase...